Navigation Links
GST Protein Active from BioVision

ProductsGST Protein Active from BioVision
Company BioVision
Item GST Protein Active
Price $99.00
Description Active GST Protein
Info BioVisionBioVision
BioVision, Inc.
980 Linda Vista Avenue
Mountain view, CA 94043



Call BioVision to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-265-1540
Customer Service: 800-891-9699
Fax Number: 650-428-0336
Web Site: http://www.biovision.com/
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Mouse Anti-Protein S Monoclonal Antibody, Unconjugated, Clone HYB 232-02 from Abcam
2. S-Protein Agarose from Novagen
3. Rabbit Anti-Human Vitamin K-dependent Protein S (PROS1) Polyclonal Antibody, Unconjugated from Lifespan Biosciences
4. S-Protein Agarose from Novagen
5. S-Protein Agarose from Novagen
6. Standard Protein Kinase Substrate (PKS) Peptide Microarray from LC Sciences
7. Protein 295 ex from HORIBA Jobin Yvon
8. ProteomeLab PA 800 Protein Characterization System from Beckman Coulter
9. ProteomeLab PF 2D Protein Fractionation System from Beckman Coulter
10. Protein Kinase Substrate (PKS) Peptide Microarray - Comprehensive Service from LC Sciences
11. Imaging Mass Spectrometry for Small Molecule Localization from Protein Discovery, Inc.
Breaking Biology News(10 mins):The Academy of Natural Sciences and Temple Press revive rare natural history work in new book 2Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 2Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 3Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 4Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 5Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 6Chefs Participate in Weight Watchers National Lose For Good 28TM 29 Campaign With Chefs Lose For Good Initiative at the 2009 Food Network New York Cit 57365 1Chefs Participate in Weight Watchers National Lose For Good 28TM 29 Campaign With Chefs Lose For Good Initiative at the 2009 Food Network New York Cit 57365 2Chefs Participate in Weight Watchers National Lose For Good 28TM 29 Campaign With Chefs Lose For Good Initiative at the 2009 Food Network New York Cit 57365 3Chefs Participate in Weight Watchers National Lose For Good 28TM 29 Campaign With Chefs Lose For Good Initiative at the 2009 Food Network New York Cit 57365 4Capital BlueCross to Cover Administration Costs of H1N1 Vaccine for Fully Insured Groups Individuals This Flu Season 57361 1Capital BlueCross to Cover Administration Costs of H1N1 Vaccine for Fully Insured Groups Individuals This Flu Season 57361 2CELLECTA INC to Develop New Approach for Cancer Gene Discovery in Partnership with Roswell Park Cancer Institute and Health Research Inc 14095 1CELLECTA INC to Develop New Approach for Cancer Gene Discovery in Partnership with Roswell Park Cancer Institute and Health Research Inc 14095 2CELLECTA INC to Develop New Approach for Cancer Gene Discovery in Partnership with Roswell Park Cancer Institute and Health Research Inc 14095 3
Breaking Biology Technology:Dip ordinary paper into ink infused with nanotubes and nanowires to create an instant battery 2Myriant Technologies LLC Selected for $50 Million Award for Succinic Acid Biorefinery Project 2Enerkem Awarded $50 Million Funding by U.S. Department of Energy for its Mississippi Biorefinery Project 2Enerkem Awarded $50 Million Funding by U.S. Department of Energy for its Mississippi Biorefinery Project 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6